C07K 14/14
Reoviridae
Official title: Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
C07K14/14 (Reoviridae) appears on 10 US grants and 18 published applications in this corpus.
Search patents in C07K- Granted patents
- 10
- Published applications
- 18
- Assignees
- 19
- Inventors
- 48
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 3 | 2 |
| 2022 | 0 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 118 Mar 2025US 12,252,704 B2ModernaTX, Inc.
- Method for producing artificial recombinant rotavirus8 Oct 2024US 12,109,262 B2Osaka University
- Method for producing artificial recombinant rotavirus25 Jul 2023US 11,707,516 B2Osaka University
- Protein muNS that can form inclusions in the endoplasmic reticulum, methods for the use thereof and uses of same16 Nov 2021US 11,174,485 B2Universid Ade De Santiago De Compostela
- Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 111 May 2021US 11,001,861 B2ModernaTX, Inc.
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Rotavirus vaccines4 Sep 2025US 2025/0276053 A1VST LLC dba Medgene
- Methods and materials for improved immunoassays using synthetic antigens28 Mar 2024US 2024/0102998 A1The Terasaki Innovation Center
- Engineered bacteria for use in vaccine compositions13 Jul 2023US 2023/0218684 A1Colorado State University Research Foundation
- Phagocytosed self-assembling proteins5 Jan 2023US 2023/0000909 A1Cell Guidance Systems Limited
Most cited
By later US patents